EA201391371A1 - Фармацевтическая композиция ситаглиптина - Google Patents

Фармацевтическая композиция ситаглиптина

Info

Publication number
EA201391371A1
EA201391371A1 EA201391371A EA201391371A EA201391371A1 EA 201391371 A1 EA201391371 A1 EA 201391371A1 EA 201391371 A EA201391371 A EA 201391371A EA 201391371 A EA201391371 A EA 201391371A EA 201391371 A1 EA201391371 A1 EA 201391371A1
Authority
EA
Eurasian Patent Office
Prior art keywords
citagliptine
pharmaceutical composition
pharmaceutical compositions
sitagliptin
compositions
Prior art date
Application number
EA201391371A
Other languages
English (en)
Other versions
EA029539B8 (ru
EA029539B1 (ru
Inventor
Мая Прескар
Весна Крошель
Сабина Трошт
Луция Хвалец
Ален Кляйиц
Полона Буковец
Original Assignee
Крка, Товарна Здравил, Д.Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Товарна Здравил, Д.Д., Ново Место filed Critical Крка, Товарна Здравил, Д.Д., Ново Место
Publication of EA201391371A1 publication Critical patent/EA201391371A1/ru
Publication of EA029539B1 publication Critical patent/EA029539B1/ru
Publication of EA029539B8 publication Critical patent/EA029539B8/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Abstract

Настоящее изобретение относится к стабильным фармацевтическим композициям, содержащим аморфный ситаглиптин, а также к способам получения этих композиций. Фармацевтические композиции получают из раствора, содержащего ситаглиптин и ингибитор кристаллизации.
EA201391371A 2011-03-29 2012-03-29 Фармацевтическая композиция ситаглиптина EA029539B8 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI201100115 2011-03-29
PCT/EP2012/055736 WO2012131005A1 (en) 2011-03-29 2012-03-29 Pharmaceutical composition of sitagliptin

Publications (3)

Publication Number Publication Date
EA201391371A1 true EA201391371A1 (ru) 2014-02-28
EA029539B1 EA029539B1 (ru) 2018-04-30
EA029539B8 EA029539B8 (ru) 2018-06-29

Family

ID=45922684

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201391371A EA029539B8 (ru) 2011-03-29 2012-03-29 Фармацевтическая композиция ситаглиптина

Country Status (4)

Country Link
EP (1) EP2691083B1 (ru)
EA (1) EA029539B8 (ru)
SI (1) SI2691083T1 (ru)
WO (1) WO2012131005A1 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2788352A1 (en) * 2011-12-08 2014-10-15 Ranbaxy Laboratories Limited Amorphous form of sitagliptin salts
IN2014MU00212A (ru) * 2014-01-21 2015-08-28 Cadila Healthcare Ltd
PL3102187T3 (pl) 2014-02-03 2020-10-19 Galenicum Health S.L. Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu
IN2014MU00651A (ru) 2014-02-25 2015-10-23 Cadila Healthcare Ltd
CN108144065B (zh) * 2016-12-06 2023-05-16 江苏恒瑞医药股份有限公司 一种dpp-4抑制剂的药物组合物
MX2016016260A (es) 2016-12-08 2018-06-07 Alparis Sa De Cv Nuevas formas solidas de sitagliptina.
CN111511365A (zh) * 2017-11-10 2020-08-07 分散技术有限责任公司 改进的药物制剂
WO2021076066A1 (en) 2019-10-14 2021-04-22 Santa Farma İlaç Sanayi̇ A.Ş. Oral formulations comprising sitagliptin hci monohydrate with improved pharmaceutical characteristics
EP3811930A1 (en) * 2019-10-24 2021-04-28 Authenda Pharmaceuticals AG Oral gliptin compositions and method for preparation thereof
GR1010089B (el) 2020-09-15 2021-09-27 Φαρματεν Α.Β.Ε.Ε. Στερεη φαρμακοτεχνικη μορφη περιεχουσα σιταγλιπτινη και μεθοδος παρασκευης αυτης
CN116459227A (zh) * 2023-05-11 2023-07-21 宙晟智维生命科学(上海)有限公司 一种西格列汀片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
JO2625B1 (en) 2003-06-24 2011-11-01 ميرك شارب اند دوم كوربوريشن Phosphoric acid salts of dipeptidyl betidase inhibitor 4
AU2004268024B2 (en) 2003-09-02 2007-07-12 Merck Sharp & Dohme Llc Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
WO2005030127A2 (en) 2003-09-23 2005-04-07 Merck & Co., Inc. Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
WO2005072530A1 (en) 2004-01-16 2005-08-11 Merck & Co., Inc. Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
EP1796671A4 (en) 2004-09-15 2009-01-21 Merck & Co Inc AMORPHOUS FORM OF A PHOSPHORIC ACID SALT OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR
US20090221592A1 (en) 2005-07-25 2009-09-03 Ellison Martha E Dodecylsulfate Salt Of A Dipeptidyl Peptidase-Iv Inhibitor
KR20070111099A (ko) 2006-05-16 2007-11-21 영진약품공업주식회사 시타글립틴 염산염의 신규 결정형, 이의 제조 방법과 이를포함하는 약학적 조성물
SI2032521T1 (sl) * 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
US20080064701A1 (en) * 2007-04-24 2008-03-13 Ramesh Sesha Anti-diabetic combinations
US20070172525A1 (en) * 2007-03-15 2007-07-26 Ramesh Sesha Anti-diabetic combinations
US8334385B2 (en) 2007-11-02 2012-12-18 Glenmark Generics Limited Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof
US20090221595A1 (en) 2007-11-26 2009-09-03 Nurit Perlman Crystalline form of sitagliptin
EP2679590A1 (en) 2007-12-20 2014-01-01 Dr. Reddy's Laboratories Ltd. Processes for the Preparation of Sitagliptin and Pharmaceutically acceptable Salts thereof
MX2010009731A (es) * 2008-03-04 2010-09-30 Merck Sharp & Dohme Composiciones farmaceuticas de una combinacion de metformina y un inhibidor de dipeptidil peptidasa-iv.
WO2009120746A2 (en) 2008-03-25 2009-10-01 Teva Pharmaceutical Industries Ltd. Crystalline forms of sitagliptin phosphate
US20090247532A1 (en) 2008-03-28 2009-10-01 Mae De Ltd. Crystalline polymorph of sitagliptin phosphate and its preparation
EP2586782B2 (en) 2008-07-03 2017-10-04 ratiopharm GmbH Crystalline salts of sitagliptin
US20100069637A1 (en) 2008-07-29 2010-03-18 Medichem S.A. CRYSTALLINE SALT FORMS OF A 5,6,7,8-TETRAHYDRO-1,2,4-TRIAZOLO[4,3-a]PYRAZINE DERIVATIVE
US8476437B2 (en) 2008-08-27 2013-07-02 Cadila Healthcare Limited Process for preparation of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine and new impurities in preparation thereof
EP2218721A1 (en) 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
CA2757241A1 (en) 2009-03-30 2010-10-14 Teva Pharmaceutical Industries Ltd. Solid state forms of sitagliptin salts
WO2010122578A2 (en) 2009-04-20 2010-10-28 Msn Laboratories Limited Process for the preparation of sitagliptin and its intermediates
WO2010131035A1 (en) 2009-05-11 2010-11-18 Generics [Uk] Limited Novel crystalline polymorph of sitagliptin dihydrogen phosphate
MX2012011460A (es) * 2010-04-08 2012-11-23 Squibb Bristol Myers Co Analogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119.
MX2013002146A (es) * 2010-09-03 2013-04-03 Astrazeneca Uk Ltd Formulaciones farmaceuticas que utilizan antioxidantes solubles en agua.
WO2012076973A2 (en) * 2010-12-09 2012-06-14 Aurobindo Pharma Limited Novel salts of dipeptidyl peptidase iv inhibitor

Also Published As

Publication number Publication date
EP2691083A1 (en) 2014-02-05
WO2012131005A1 (en) 2012-10-04
EA029539B8 (ru) 2018-06-29
SI2691083T1 (sl) 2017-12-29
EP2691083B1 (en) 2017-08-02
EA029539B1 (ru) 2018-04-30

Similar Documents

Publication Publication Date Title
EA201391371A1 (ru) Фармацевтическая композиция ситаглиптина
EA202190619A1 (ru) Противовирусные соединения
CY1119245T1 (el) Φαρμακευτικη συνθεση καρβετοκινης
EA201301181A1 (ru) Триазолопиридины
EA201590868A1 (ru) Противовирусные соединения
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
EA201590879A1 (ru) Арилконденсированные и гетероарилконденсированные лактамы
EA201690899A1 (ru) Оксазепины в качестве модуляторов ионных каналов
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201301209A1 (ru) Производные пирролотриазинона в качестве ингибиторов p13k
EA201391532A1 (ru) Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA201790963A1 (ru) Противовирусные соединения
EA201391561A1 (ru) Новые соединения-модуляторы gpr-119
EA201391145A1 (ru) Способы получения хинолиновых соединений и фармацевтических композиций, содержащих такие соединения
EA201301019A1 (ru) Бензодиоксановые ингибиторы продуцирования лейкотриена
EA201391274A1 (ru) Аминохинолины в качестве ингибиторов киназ
EA201390579A1 (ru) Производные хиназолин-4(3h)-она, используемые как ингибиторы pi3-киназы
EA201490272A1 (ru) Новые 4-пиперидинильные соединения для применения в качестве ингибиторов танкиразы
EA201691216A1 (ru) Композиции линаклотида с замедленным высвобождением
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201300388A1 (ru) Соединения замещенного бензамида
EA201492287A1 (ru) Дейтерированные производные руксолитиниба

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM